The effects of putative AD therapeutics on CSF biomarkers in aged dogs provides a rapid screen in a higher mammalian model that naturally develops AD-like pathology. We have experience in conducting relatively rapid screens for studying the effect of multiple NCEs on CSF biomarkers to support the lead optimization process which can be followed up with more extensive studies on selected compounds.